January 30, 2019 @ 5:30 pm – 7:30 pm
JW Marriott Marquis Miami

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents


5:30 PM – 6:00 PM Registration / Dinner
6:00 PM – 7:30 PM Meeting


JW Marriott Marquis Miami
255 Biscayne Blvd Way
Miami, FL 33131
Meeting Room: Plaza 4 & 5

1.5 CME/CNE Credits: A 3D View!



  • Interactive, case-based learning environment
  • Create your own Personalized Poster
  • iPads provided to enhance learning experience and enable real-time Q&A


To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 207-406-4248.


Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC 

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, LA


I. Overview of headache disorders

  • The burden of migraine: epidemiology, disability and quality of life, economic burden
  • Migraine and other primary headaches: classification and diagnosis of primary headache disorders
  • Patient video showing the process of differential diagnosis – leading into treatment

II The current challenges and needs in migraine management

  • Expanding role for primary care providers and doctors of osteopathy
  • Evidence-based approach to acute and preventive treatment of migraine
  • Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
  • Migraine prevention: what are the current unmet needs?
  • Improving patient/physician and physician/physician communication

III. Targeting CGRP or its receptor: a new era in targeting migraine underlying pathology

  • Role of CGRP in the trigeminovascular system and in migraine
    • Mechanism of action of gepants and mAbs to CGRP or its receptor
  • Update of recently released data from clinical trials
  • Safety
  • Patient-reported outcomes
  • Interactive case studies, including refractory chronic migraine cases
  • Improving patient/physician and physician/physician communication

IV. Neuromodulation: a brief update

V. Conclusions and Q&A


  • Review best practices for diagnosing migraine headaches including the process of differential diagnosis
  • Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
  • Describe burdens associated with migraine headaches and the use of patient-reported outcomes for measuring the impact of new and established migraine therapies
  • Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for overcoming patient- and physician-dependent barriers in clinical practice

This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.5 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM Maintenance of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 AOA Credit:
The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this live program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this live activity.

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/ 

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com